Genome editing technologies have swept news headlines for their ability to improve human health in revolutionary ways. At the forefront are CRISPR-Cas9-based systems which allow the alteration and editing of human DNA, creating the potential to treat disease at its genetic roots. Dr. Feng Zhang has pioneered the development of Cas9-based technologies and has continued to expand the CRISPR toolbox by adding other systems, including Cas13-based systems that target RNA for therapeutic and diagnostic applications.
Join Dr. Zhang for one night only to hear firsthand his research and insights around the groundbreaking innovation of CRISPR-based technologies, as well as the new horizons of genome editing that will continue to accelerate biomedical research around the world and improve health for all humanity.
Reception with cash bar and light bites to follow.
Funding provided by the Lee and Nile Albright Annual Symposium Fund. This program is free, thanks to the generosity of the Lowell Institute.
This program is for audiences 18+.
For information about accessibility in the Museum: mos.org/accessibility. For questions or accommodation requests: 617-723-2500, firstname.lastname@example.org. Please request ASL interpreters at least two weeks in advance.
Recommended for: Visitors 18 years of age and older
Dr. Feng Zhang is a core member of the Broad Institute, investigator at the McGovern Institute for Brain Research, the James and Patricia Poitras Professor of Neuroscience at MIT, and a Howard Hughes Medical Institute Investigator.
© 1996-2020 Museum of Science, Boston – All rights reserved.